What is New Objective?
New Objective is a leader in advanced PicoTip technologies, empowering global life science research through sophisticated mass spectrometry solutions. With a legacy spanning over 25 years, the company provides a comprehensive suite of products, including high-performance nanospray emitters, columns, and sources, all engineered for optimal proteomics workflows. Their innovative offerings, such as PicoChip and FlowChip, are designed for both nanoflow and microflow applications, ensuring exceptional reproducibility and efficiency for researchers worldwide. Serving clients in over 40 countries, New Objective's technologies have been instrumental in advancing scientific understanding, contributing to more than 10,000 peer-reviewed publications.
How much funding has New Objective raised?
New Objective has raised a total of $375K across 2 funding rounds:
Debt
$150K
Debt
$225K
Debt (2020): $150K with participation from PPP
Debt (2021): $225K led by PPP
What's next for New Objective?
The recent major strategic investment signifies a pivotal moment for New Objective, indicating a strong market validation and providing the capital necessary for accelerated growth and innovation. As a company operating in the large-scale late-stage funding environment, this infusion of capital is likely to be directed towards expanding market reach, enhancing product development in PicoTip technologies, and potentially exploring new applications within the proteomics and broader life science research fields. This strategic financing will enable New Objective to further solidify its competitive advantage and continue its trajectory of supporting critical scientific advancements globally.
See full New Objective company page
